Patents by Inventor Herman Russ

Herman Russ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERVAL THERAPY FOR THE TREATMENT OF TINNITUS
    Publication number: 20110086916
    Abstract: The present invention relates to interval and/or maintenance therapy employing 1-amino-alkylcyclohexane derivatives (e.g., neramexane or a pharmaceutically acceptable salt thereof) for the treatment of an individual afflicted with tinnitus.
    Type: Application
    Filed: September 10, 2008
    Publication date: April 14, 2011
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Barbara Ellers-Lenz, Tanja Rosenberg, Micael Althaus, Herman Russ, Hagen Kruger
  • Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
    Patent number: 7872030
    Abstract: (R/S)-(?/+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane or a physiologically acceptable salt thereof and/or (S)-(+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane or a physiologically acceptable salt thereof are used for the manufacture of a medicament for the treatment of extrapyramidal movement disorders and/or adverse effects in extrapyramidal movement disorders.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: January 18, 2011
    Assignee: Merck Patent GmbH
    Inventors: Gerd Bartoszyk, Herman Russ, Christoph Seyfried, Frank Weber
  • THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES
    Publication number: 20100204137
    Abstract: Methods for the prevention and treatment of ocular disorders, in particular glaucoma, through blocking the toxic effects of ?-amyloid (A?) derivatives, and pharmaceutical compositions for effecting such prevention and treatment thereof.
    Type: Application
    Filed: August 21, 2008
    Publication date: August 12, 2010
    Applicant: MERZ PHARMAGMBH & CO. KGaA
    Inventor: Herman Russ
  • Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
    Publication number: 20040171645
    Abstract: (R/S)-(±)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane or a physiologically acceptable salt thereof and/or (S)-(+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane or a physiologically acceptable salt thereof are used for the manufacture of a medicament for the treatment of extrapyramidal movement disorders and/or adverse effects in extrapyramidal movement disorders.
    Type: Application
    Filed: January 26, 2004
    Publication date: September 2, 2004
    Inventors: Gerd Bartoszyk, Herman Russ, Christoph Seyfried, Frank Weber